Journals / İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi / 2022 / Sayı: 16

Evaluation of the Fear of Covid 19 and the Use of Health Services in Individuals With Chronic Disease

Kronik Hastalığı Olan Bireylerde Covid 19 Korkusu ve Sağlık Hizmetlerini Kullanma Durumlarının Değerlendirilmesi

Pages
98–113
Publication Date
2022-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: This study was conducted to evaluate the fear of Covid 19 and the use of health services in individuals over the age of 18 who were diagnosed with a chronic disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study was conducted to evaluate the fear of Covid 19 and the use of health services in individuals over the age of 18 who were diagnosed with a chronic disease.
📊
Key Findings & Data:Aim: This study was conducted to evaluate the fear of Covid 19 and the use of health services in individuals over the age of 18 who were diagnosed with a chronic disease.
💡
Conclusion & Impact:Aim: This study was conducted to evaluate the fear of Covid 19 and the use of health services in individuals over the age of 18 who were diagnosed with a chronic disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Covid 19 · korku · pandemik

Abstract

Aim: This study was conducted to evaluate the fear of Covid 19 and the use of health services in individuals over the age of 18 who were diagnosed with a chronic disease.

Özet

Amaç: Bu çalışma, kronik hastalık tanısı almış 18 yaş üstü bireylerin Covid 19 korkusunu ve sağlık hizmetlerini kullanma durumlarını değerlendirmek amacıyla yapılmıştır.

🔖

Cite This Article

YILDIRIM, T. A., GEBEŞOĞLU, N. (2022). Evaluation of the Fear of Covid 19 and the Use of Health Services in Individuals With Chronic Disease. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 16, 98–113. https://ajindex.com/articles/675895

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Zhu, N, Zhang, D, Wang, W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.
  2. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Abai B, Abu-Ghosh A, eds. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2020. T.C. Sağlık Bakanlığı. Covid-19 (Sars-Cov-2 Enfeksiyonu) Genel Bilgiler, Epidemiyoloji ve Tanı Rehberi. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Bilimsel Danışma Kurulu Çalışması. T.C. Sağlık Bakanlığı. https://covid19.saglik.gov.tr/Eklenti/39551/0/covid19rehberigenelbilgilerepidemiyolojivetanipdf.pdf. Yayınlama tarihi 2020. Erişim Tarihi 01 Haziran 2021. World Health Organization. World Health Organization [WHO] WHO Coronavirus Disease (COVID-19) Dashboard, 2021. World Health Organization. https://covid19.who.int/.Erişim tarihi 15 Eylül 2021. T.C. Sağlık Bakanlığı. T.C. Sağlık Bakanlığı, Genel Koronavirüs Tablosu 2021. T.C. Sağlık Bakanlığı. https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus tablosu.html?gclid=EAIaIQobChMI9YHjtv7o7QIVFeR3Ch2RYgE7EAAYASAAEgLBS_D_BwE. Yayınlanma tarihi 2021. Erişim tarihi 02 Eylül 2021. World Health Organization. World Health Organization (WHO) Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities 2020. World Health Organization. file:///C:/Users/user/Downloads/WHO-2019-nCoV-vaccination-IPC-2021.1-eng.pdf. Yayınlama tarihi: 2020. Erişim tarihi 19 Ocak 2021.
  3. Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17:1729-53. doi:10.3390/ijerph17051729. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-1069.
  4. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. doi:10.1016/j.ijid.2020.03.017 32173574. Gökçe Kutsal Y, Aslan D. COVID-19 Pandemi Sürecinde İleri Yaş Grubuna Yaklaşım, Ankara, Türkiye: Türk Geriatri Derneği; 2020;3-10.
  5. Chudasama YV, Gillies, CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab S